Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$259.0 - $414.71 $6,475 - $10,367
-25 Closed
0 $0
Q2 2020

Aug 07, 2020

SELL
$258.66 - $342.55 $1.79 Million - $2.37 Million
-6,920 Reduced 99.64%
25 $6,000
Q1 2020

May 13, 2020

SELL
$268.85 - $341.04 $401,930 - $509,854
-1,495 Reduced 17.71%
6,945 $2.2 Million
Q4 2019

Feb 13, 2020

SELL
$220.06 - $304.07 $213 Million - $295 Million
-969,416 Reduced 99.14%
8,440 $2.5 Million
Q3 2019

Nov 12, 2019

SELL
$217.44 - $243.88 $12.6 Million - $14.2 Million
-58,074 Reduced 5.61%
977,856 $228 Million
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $62.2 Million - $68.6 Million
-283,856 Reduced 21.51%
1,035,930 $242 Million
Q1 2019

May 14, 2019

SELL
$216.71 - $338.96 $130 Million - $203 Million
-597,888 Reduced 31.18%
1,319,786 $312 Million
Q4 2018

Feb 13, 2019

SELL
$278.5 - $352.75 $90.3 Million - $114 Million
-324,104 Reduced 14.46%
1,917,674 $577 Million
Q3 2018

Nov 09, 2018

BUY
$293.51 - $383.83 $35.5 Million - $46.5 Million
121,072 Added 5.71%
2,241,778 $792 Million
Q2 2018

Aug 13, 2018

BUY
$257.52 - $306.91 $31.7 Million - $37.8 Million
123,007 Added 6.16%
2,120,706 $616 Million
Q1 2018

May 14, 2018

SELL
$260.13 - $367.91 $17.8 Million - $25.1 Million
-68,323 Reduced 3.31%
1,997,699 $547 Million
Q4 2017

Feb 13, 2018

SELL
$307.64 - $344.58 $56.4 Million - $63.1 Million
-183,231 Reduced 8.15%
2,066,022 $658 Million
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $632 Million - $742 Million
2,249,253
2,249,253 $704 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.4B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Jackson Square Partners, LLC Portfolio

Follow Jackson Square Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Partners, LLC with notifications on news.